Sort
51,593 grants matching “hepatitis”
Biliary Atresia Consortium: Data Coordinating Center
$991,159John C Magee · University Of Michigan At Ann Arbor · U01 · FY2007 · DK
Adjuvanted DNA Vaccine for Immunotherapy HIV Infection
$991,097Powderject Vaccines, Inc. · P01 · FY2001 · AI
TLR4 and TGF-beta interactions in HCC induced by HCV and alcohol
$990,970Hidekazu Tsukamoto · University Of Southern California · RC2 · FY2009 · AA
Targeting SWELL1 Signaling to Treat Obesity-Induced Type 2 Diabetes
$990,929Daniel J Lerner · Senseion Therapeutics, Inc. · R44 · FY2022 · DK
HIV and HCC in Africa: The H2A Consortium
$990,617Gregory D Kirk · Johns Hopkins University · U54 · FY2022 · CA
A Topical Non Steroidal Anti-inflammatory for Rosacea
$990,578Edwardo Eddie Perez · Signum Biosciences · R44 · FY2012 · AI
Rapid, Point-of-Care Nucleic Acid Test for HCV
$990,440Hyundae Cho · Crosslife Technologies, Inc. · R44 · FY2020 · DK
HIV and HCC in Africa: The H2A Consortium
$990,369Gregory D Kirk · Johns Hopkins University · U54 · FY2023 · CA
Ethical, Legal and Social Issues for Precision Medicine and Infectious Disease
$990,267Gail Geller · Johns Hopkins University · RM1 · FY2019 · HG
reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)
$990,189Jose Szapocznik · University Of Miami School Of Medicine · R01 · FY2023 · DA
Nuclear receptors: action, functions, and roles in disease
$989,992Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES
Development of a Novel MRI Contrast Agent for Early Detection of Alcoholic Steatohepatitis
$989,930Jenny J Yang · Inlighta Biosciences, Llc · UT2 · FY2020 · AA
Identification and Characterization of Signaling Pathways and Mediators Regulating Mast Cell-Related Disorders
$989,897Ana Olivera · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Development of an H2O2-inactivated chikungunya virus vaccine
$989,109Ian James Amanna · Najit Technologies, Inc. · R44 · FY2019 · AI
Case Proteomics Center for HIV/AIDS and Drug Abuse
$989,108Mark R Chance · Case Western Reserve University · P20 · FY2009 · DA
A preclinical multi-modal system for dynamic noninvasive assessment of liver disease
$989,080Tomasz Joseph Czernuszewicz · Sonovol, Inc. · SB1 · FY2021 · DK
Systems Biology Approach to Identifying Biomarkers for Alcoholic Liver Disease
$988,920Ali Keshavarzian · Rush University Medical Center · RC2 · FY2009 · AA
HIV and HCC in Africa: The H2A Consortium
$988,451Gregory D Kirk · Johns Hopkins University · U54 · FY2021 · CA
Xenobiotic Receptors
$988,205Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Pathogenesis Of Enteric Viral Hepatitis
$988,057Robert H. Purcell · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
NSF-ANR MCB/PHY: Virus self-assembly, from test tube to cell cytoplasm
$987,566William M Gelbart · University Of California-Los Angeles · · FY2024 · BIO
HIV and HCC in Africa: The H2A Consortium
$987,283Gregory D Kirk · Johns Hopkins University · U54 · FY2024 · CA
Reperfusion Injury Protection Strategies During Basic Life Support
$986,671Demetris Yannopoulos · University Of Minnesota · R01 · FY2014 · HL
rhMFG-E8 as an Effective Adjuvant Therapy for Hemorrhagic Shock
$986,433Max Brenner · Therasource, Llc · R44 · FY2021 · HL
Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans
$986,138Matthew S Freiberg · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · HL